Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
 Disease Category: Endometriosis
Location: United States, OR

Trial Information

Do you have Mild to Moderate Endometriosis?

Phase 3, double-blind, placebo-controlled, randomized study evaluating the safety and efficacy of study med in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects.

Up to 12 Office Visits

Patient Inclusion Criteria

  • Age 18-49
  • Subject is a premenopausal female, between 18 and 49 years of age, inclusive, at the time of signing consent
  • Subject has a clinical diagnosis of endometriosis established by means of documented surgicalvisualization (laparoscopy or laparotomy) performed within 7 years of screening

Patient Exclusion Criteria

  • Subject has a previous history of a severe, life-threatening or other significant sensitivity to any drug.
  • Subject is less than 6 months postpartum, post-abortion, or post-pregnancy at the time of entry into the Screening Period.

Toni Myers, Site Manager
Clinical Trials of America, Inc
10 Coburg Road, Suite 200
Eugene, OR 97401
Phone: 541-349-0523
Email: tonim@ctofa.com

View Map

Research Center Information: Clinical Trials of America, Inc

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.